Strategic nanoparticle-mediated plant disease resistance

Crit Rev Biotechnol. 2023 Feb;43(1):22-37. doi: 10.1080/07388551.2021.2007842. Epub 2022 Mar 13.

Abstract

Nanotechnology is a promising means for development of sustainable agriculture while the study of nanoparticle-mediated plant disease resistance is still in its primary stage. Nanotechnology has shown great promise in regulating: the content of secondary metabolites, inducing disease resistance genes, delivering hormones, delivering biomolecules (such as: nucleotides, proteins, and activators), and obtaining transgenic plants to resist plant diseases. In this review, we conclude its versatility and applicability in disease management strategies and diagnostics and as molecular tools. With the advent of new biotechnologies (e.g. de novo regeneration, CRISPR/Cas9, and GRF4-GIF1 fusion protein), we discuss the potential of nanoparticles as an optimal platform to deliver biomolecules to plants for genetic engineering. In order to ensure the safe use and social acceptance of plant nanoparticle technology, its adverse effects are discussed, including the risk of transferring nanoparticles through the food chain.

Keywords: Cas9/CRISPR; Nanoparticle; de novo regeneration; gene transformation.

Publication types

  • Review

MeSH terms

  • CRISPR-Cas Systems
  • Disease Resistance / genetics
  • Gene Editing*
  • Genome, Plant
  • Nanoparticles*
  • Plant Diseases / prevention & control
  • Plants, Genetically Modified / genetics